News
AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...
4don MSN
The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...
When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...
2d
NDTV Profit on MSNAstraZeneca sets up ₹166 cr Global Hub to boost AI driven healthcareGlobal bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...
Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...
BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs ...
AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...
Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's ...
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...
This expansion will support the company’s AI-powered innovation across R&D, global business services, IT, and digital health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results